Announcements Trials
Browse Landscape

Phase

Phase 2 108Phase 1 43Phase 3 36Phase NA 31Phase 1/2 20Phase 4 10Phase EARLY_PHASE1 2Phase 2/3 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Other hematologic neoplasm 1Myeloid 1

Conditions

Sarcoma 10Osteosarcoma 5Bone Neoplasms 5Neurofibrosarcoma 3Neoplasms 3Lung Neoplasms 3Liposarcoma 3Leiomyosarcoma 3Sarcoma, Synovial 2Sarcoma, Ewing 2Sarcoma, Alveolar Soft Part 2Nerve Sheath Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Histiocytoma, Malignant Fibrous 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2Fibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1Sarcoma, Clear Cell 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

regorafenib 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Gastrointestinal Stromal Tumors × Sarcoma × Clear all
NCT07379047 2026-04-24

GISTAR-1

Ningbo Newbay Technology Development Co., Ltd

Phase 2/3 Not yet recruiting
255 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02103322 2014-06-27

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Amneal Pharmaceuticals, LLC

Phase 2/3 Completed
48 enrolled
GastrointestinalMyeloidOther hematologic neoplasmSarcoma

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡